Company Filing History:
3 out of 776 
2 out of 1,248 
2 out of 55 
Years Active: 1993-2015
Title: Ralf Plate: Innovator in Pharmaceutical Compounds
Introduction
Ralf Plate is a notable inventor based in Oss, Netherlands, recognized for his contributions to the field of pharmaceutical compounds. With a total of eight patents to his name, he has made significant strides in developing innovative solutions for various medical conditions.
Latest Patents
Among his latest patents is the invention related to TSH receptor antagonizing tetrahydroquinoline compounds. This invention focuses on the use of a compound, a pharmaceutical composition, and a kit for treating or preventing disorders in mammals that are responsive to TSH receptor mediated pathways. These disorders include hyperthyroidism, Graves' disease, Graves Ophthalmopathy, Graves' associated pretibial dermopathy, nodular goitre, and thyroid cancer. The invention involves administering an effective amount of a tetrahydroquinoline compound or a pharmaceutically acceptable salt thereof.
Another significant patent by Ralf Plate involves non-steroidal compounds useful as glucocorticoid receptor modulators. This invention pertains to novel amino acid derivatives that exhibit high specificity for the glucocorticoid receptor, making them valuable for treating inflammatory diseases. The detailed formula of these compounds showcases their potential in pharmaceutical applications.
Career Highlights
Ralf Plate has had a distinguished career, working with prominent companies such as Akzo N.V. and Akzo Nobel N.V. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical solutions.
Collaborations
Throughout his career, Ralf has collaborated with notable colleagues, including Johannes H. Wieringa and Christiaan Gerardus Johannes Maria Jans. These collaborations have likely enriched his research and development efforts, leading to impactful inventions.
Conclusion
Ralf Plate's work in the field of pharmaceutical compounds demonstrates his commitment to innovation and improving healthcare outcomes. His patents reflect a deep understanding of complex medical conditions and a drive to create effective treatments.